TY - STD TI - Gajdacs M, Albericio F. Antibiotic resistance: from the bench to patients. Antibiotics. 2019;8 (3):129. ID - ref1 ER - TY - JOUR AU - Shaowei, Z. AU - Ping, L. I. AU - Zhang, Z. AU - Zhengliang, P. H. PY - 2019 DA - 2019// TI - CHINET surveilance of carbapenem-resistant gram-negative bacteria in China from 2005 to 2017 JO - J Clin Emerg (China) VL - 20 ID - Shaowei2019 ER - TY - JOUR AU - Hu, F. AU - Guo, Y. AU - Zhu, D. AU - Wang, F. AU - Jiang, X. AU - Fu, Y. AU - Xiaolong, Z. PY - 2020 DA - 2020// TI - CHINET surveillance of bacterial resistance in China: 2018 report JO - Chin J Infect Chemother VL - 20 ID - Hu2020 ER - TY - JOUR AU - Brink, A. J. PY - 2019 DA - 2019// TI - Epidemiology of carbapenem-resistant gram-negative infections globally JO - Curr Opin Infect Dis VL - 32 UR - https://doi.org/10.1097/QCO.0000000000000608 DO - 10.1097/QCO.0000000000000608 ID - Brink2019 ER - TY - STD TI - Gajdacs M, Batori Z, Abrok M, Lazar A, Burian K. Characterization of resistance in gram-negative urinary isolates using existing and novel indicators of clinical relevance: a 10-year data analysis. Life. 2020;10(2):16. ID - ref5 ER - TY - JOUR AU - Harbarth, S. AU - Garbino, J. AU - Pugin, J. AU - Romand, J. A. AU - Lew, D. AU - Pittet, D. PY - 2003 DA - 2003// TI - Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis JO - Am J Med VL - 115 UR - https://doi.org/10.1016/j.amjmed.2003.07.005 DO - 10.1016/j.amjmed.2003.07.005 ID - Harbarth2003 ER - TY - JOUR AU - Boucher, H. W. AU - Talbot, G. H. AU - Bradley, J. S. AU - Edwards, J. E. AU - Gilbert, D. AU - Rice, L. B. AU - Scheld, M. AU - Spellberg, B. AU - Bartlett, J. PY - 2009 DA - 2009// TI - Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America JO - Clin Infect Dis VL - 48 UR - https://doi.org/10.1086/595011 DO - 10.1086/595011 ID - Boucher2009 ER - TY - STD TI - Gajdacs M. The concept of an ideal antibiotic: implications for drug design. Molecules. 2019;24(5):892. ID - ref8 ER - TY - JOUR AU - Nielsen, E. I. AU - Friberg, L. E. PY - 2013 DA - 2013// TI - Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs JO - Pharmacol Rev VL - 65 UR - https://doi.org/10.1124/pr.111.005769 DO - 10.1124/pr.111.005769 ID - Nielsen2013 ER - TY - JOUR AU - Wang, Q. AU - Wang, X. AU - Wang, J. AU - Ouyang, P. AU - Jin, C. AU - Wang, R. AU - Zhang, Y. AU - Jin, L. AU - Chen, H. AU - Wang, Z. PY - 2018 DA - 2018// TI - Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012–2016) JO - Clin Infect Dis VL - 67 UR - https://doi.org/10.1093/cid/ciy660 DO - 10.1093/cid/ciy660 ID - Wang2018 ER - TY - JOUR AU - Nation, R. L. AU - Velkov, T. AU - Li, J. PY - 2014 DA - 2014// TI - Colistin and polymyxin B: peas in a pod, or chalk and cheese? JO - Clin Infect Dis VL - 59 UR - https://doi.org/10.1093/cid/ciu213 DO - 10.1093/cid/ciu213 ID - Nation2014 ER - TY - JOUR AU - Peterson, L. R. PY - 2008 DA - 2008// TI - A review of tigecycline--the first glycylcycline JO - Int J Antimicrob Agents VL - 32 UR - https://doi.org/10.1016/S0924-8579(09)70005-6 DO - 10.1016/S0924-8579(09)70005-6 ID - Peterson2008 ER - TY - JOUR AU - Srinivas, P. AU - Hunt, L. N. AU - Pouch, S. M. AU - Thomas, K. AU - Goff, D. A. AU - Pancholi, P. AU - Balada-Llasat, J. M. AU - Bauer, K. A. PY - 2018 DA - 2018// TI - Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates JO - Diagn Microbiol Infect Dis VL - 91 UR - https://doi.org/10.1016/j.diagmicrobio.2018.01.028 DO - 10.1016/j.diagmicrobio.2018.01.028 ID - Srinivas2018 ER - TY - JOUR AU - Burkhardt, O. AU - Rauch, K. AU - Kaever, V. AU - Hadem, J. AU - Kielstein, J. T. AU - Welte, T. PY - 2009 DA - 2009// TI - Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint JO - Int J Antimicrob Agents VL - 34 UR - https://doi.org/10.1016/j.ijantimicag.2009.01.015 DO - 10.1016/j.ijantimicag.2009.01.015 ID - Burkhardt2009 ER - TY - JOUR AU - Ooi, M. H. AU - Ngu, S. J. AU - Chor, Y. K. AU - Li, J. AU - Landersdorfer, C. B. AU - Nation, R. L. PY - 2019 DA - 2019// TI - Population pharmacokinetics of intravenous colistin in pediatric patients: implications for the selection of dosage regimens JO - Clin Infect Dis VL - 69 UR - https://doi.org/10.1093/cid/ciz067 DO - 10.1093/cid/ciz067 ID - Ooi2019 ER - TY - JOUR AU - Tumbarello, M. AU - Viale, P. AU - Viscoli, C. AU - Trecarichi, E. M. AU - Tumietto, F. AU - Marchese, A. AU - Spanu, T. AU - Ambretti, S. AU - Ginocchio, F. AU - Cristini, F. AU - Losito, A. R. AU - Tedeschi, S. AU - Cauda, R. AU - Bassetti, M. PY - 2012 DA - 2012// TI - Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy JO - Clin Infect Dis VL - 55 UR - https://doi.org/10.1093/cid/cis588 DO - 10.1093/cid/cis588 ID - Tumbarello2012 ER - TY - JOUR AU - Tsuji, B. T. AU - Pogue, J. M. AU - Zavascki, A. P. AU - Paul, M. AU - Daikos, G. L. AU - Forrest, A. AU - Giacobbe, D. R. AU - Viscoli, C. AU - Giamarellou, H. AU - Karaiskos, I. PY - 2019 DA - 2019// TI - International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) JO - Pharmacotherapy VL - 39 UR - https://doi.org/10.1002/phar.2209 DO - 10.1002/phar.2209 ID - Tsuji2019 ER - TY - JOUR AU - Roussos, N. AU - Karageorgopoulos, D. E. AU - Samonis, G. AU - Falagas, M. E. PY - 2009 DA - 2009// TI - Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections JO - Int J Antimicrob Agents VL - 34 UR - https://doi.org/10.1016/j.ijantimicag.2009.08.013 DO - 10.1016/j.ijantimicag.2009.08.013 ID - Roussos2009 ER - TY - JOUR AU - Walsh, C. C. AU - McIntosh, M. P. AU - Peleg, A. Y. AU - Kirkpatrick, C. M. AU - Bergen, P. J. PY - 2015 DA - 2015// TI - In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa JO - J Antimicrob Chemother VL - 70 UR - https://doi.org/10.1093/jac/dkv221 DO - 10.1093/jac/dkv221 ID - Walsh2015 ER - TY - JOUR AU - Yu, W. AU - Shen, P. AU - Bao, Z. AU - Zhou, K. AU - Zheng, B. AU - Ji, J. AU - Guo, L. AU - Huang, C. AU - Xiao, Y. PY - 2017 DA - 2017// TI - In vitro antibacterial activity of fosfomycin combined with other antimicrobials against KPC-producing Klebsiella pneumoniae JO - Int J Antimicrob Agents VL - 50 UR - https://doi.org/10.1016/j.ijantimicag.2017.03.011 DO - 10.1016/j.ijantimicag.2017.03.011 ID - Yu2017 ER - TY - BOOK PY - 2016 DA - 2016// TI - Performance standards for antimicrobial susceptibility testing. 26th informational supplement ID - ref21 ER - TY - JOUR AU - Hong-li, W. AU - Yan-bai, H. AU - Tao, C. AU - Yi-ming, H. PY - 2020 DA - 2020// TI - A body shape index constructed and its association with blood pressure among Chinese adults JO - Chin J Public Health VL - 36 ID - Hong-li2020 ER - TY - JOUR AU - You, H. AU - Li, X. L. AU - Jing, K. Z. AU - Li, Z. G. AU - Cao, H. M. AU - Wang, J. AU - Bai, L. AU - Gu, J. H. AU - Fan, X. AU - Gu, H. PY - 2018 DA - 2018// TI - Association between body mass index and health-related quality of life among Chinese elderly-evidence from a community-based study JO - BMC Public Health VL - 18 UR - https://doi.org/10.1186/s12889-018-6086-1 DO - 10.1186/s12889-018-6086-1 ID - You2018 ER - TY - JOUR AU - Peterson, C. M. AU - Thomas, D. M. AU - Blackburn, G. L. AU - Heymsfield, S. B. PY - 2016 DA - 2016// TI - Universal equation for estimating ideal body weight and body weight at any BMI JO - Am J Clin Nutr VL - 103 UR - https://doi.org/10.3945/ajcn.115.121178 DO - 10.3945/ajcn.115.121178 ID - Peterson2016 ER - TY - JOUR AU - Albiero, J. AU - Sy, S. K. AU - Mazucheli, J. AU - Caparroz-Assef, S. M. AU - Costa, B. B. AU - Alves, J. L. AU - Gales, A. C. AU - Tognim, M. C. PY - 2016 DA - 2016// TI - Pharmacodynamic evaluation of the potential clinical utility of fosfomycin and meropenem in combination therapy against KPC-2-producing Klebsiella pneumoniae JO - Antimicrob Agents Chemother VL - 60 UR - https://doi.org/10.1128/AAC.03099-15 DO - 10.1128/AAC.03099-15 ID - Albiero2016 ER - TY - JOUR AU - Lin, J. AU - Knight, E. L. AU - Hogan, M. L. AU - Singh, A. K. PY - 2003 DA - 2003// TI - A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease JO - J Am Soc Nephrol VL - 14 UR - https://doi.org/10.1097/01.ASN.0000088721.98173.4B DO - 10.1097/01.ASN.0000088721.98173.4B ID - Lin2003 ER - TY - JOUR AU - Parker, S. L. AU - Frantzeskaki, F. AU - Wallis, S. C. AU - Diakaki, C. AU - Giamarellou, H. AU - Koulenti, D. AU - Karaiskos, I. AU - Lipman, J. AU - Dimopoulos, G. AU - Roberts, J. A. PY - 2015 DA - 2015// TI - Population pharmacokinetics of fosfomycin in critically ill patients JO - Antimicrob Agents Chemother VL - 59 UR - https://doi.org/10.1128/AAC.01321-15 DO - 10.1128/AAC.01321-15 ID - Parker2015 ER - TY - JOUR AU - Goto, M. AU - Sugiyama, M. AU - Nakajima, S. AU - Yamashina, H. PY - 1981 DA - 1981// TI - Fosfomycin kinetics after intravenous and oral administration to human volunteers JO - Antimicrob Agents Chemother VL - 20 UR - https://doi.org/10.1128/AAC.20.3.393 DO - 10.1128/AAC.20.3.393 ID - Goto1981 ER - TY - JOUR AU - Wart, S. A. AU - Owen, J. S. AU - Ludwig, E. A. AU - Meagher, A. K. AU - Korth-Bradley, J. M. AU - Cirincione, B. B. PY - 2006 DA - 2006// TI - Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infections JO - Antimicrob Agents Chemother VL - 50 UR - https://doi.org/10.1128/AAC.01636-05 DO - 10.1128/AAC.01636-05 ID - Wart2006 ER - TY - JOUR AU - Meagher, A. K. AU - Ambrose, P. G. AU - Grasela, T. H. AU - Ellis-Grosse, E. J. PY - 2005 DA - 2005// TI - The pharmacokinetic and pharmacodynamic profile of tigecycline JO - Clin Infect Dis VL - 41 UR - https://doi.org/10.1086/431674 DO - 10.1086/431674 ID - Meagher2005 ER - TY - JOUR AU - Garonzik, S. M. AU - Li, J. AU - Thamlikitkul, V. AU - Paterson, D. L. AU - Shoham, S. AU - Jacob, J. AU - Silveira, F. P. AU - Forrest, A. AU - Nation, R. L. PY - 2011 DA - 2011// TI - Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients JO - Antimicrob Agents Chemother VL - 55 UR - https://doi.org/10.1128/AAC.01733-10 DO - 10.1128/AAC.01733-10 ID - Garonzik2011 ER - TY - STD TI - Lepak AJ, Zhao M, VanScoy B, Taylor DS, Ellis-Grosse E, Ambrose PG, et al. In vivo pharmacokinetics and pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the neutropenic murine thigh infection model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017;61(6):e00476-17. ID - ref32 ER - TY - JOUR AU - Descourouez, J. L. AU - Jorgenson, M. R. AU - Wergin, J. E. AU - Rose, W. E. PY - 2013 DA - 2013// TI - Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant enterococcus faecium from renal transplant patients with infected urinary stents JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.02099-12 DO - 10.1128/AAC.02099-12 ID - Descourouez2013 ER - TY - JOUR AU - Mazzei, T. AU - Cassetta, M. I. AU - Fallani, S. AU - Arrigucci, S. AU - Novelli, A. PY - 2006 DA - 2006// TI - Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections JO - Int J Antimicrob Agents VL - 28 UR - https://doi.org/10.1016/j.ijantimicag.2006.05.019 DO - 10.1016/j.ijantimicag.2006.05.019 ID - Mazzei2006 ER - TY - JOUR AU - DeRyke, C. A. AU - Kuti, J. L. AU - Nicolau, D. P. PY - 2007 DA - 2007// TI - Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004 JO - Pharmacotherapy VL - 27 UR - https://doi.org/10.1592/phco.27.3.333 DO - 10.1592/phco.27.3.333 ID - DeRyke2007 ER - TY - JOUR AU - Passarell, J. A. AU - Meagher, A. K. AU - Liolios, K. AU - Cirincione, B. B. AU - Wart, S. A. AU - Babinchak, T. AU - Ellis-Grosse, E. J. AU - Ambrose, P. G. PY - 2008 DA - 2008// TI - Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections JO - Antimicrob Agents Chemother VL - 52 UR - https://doi.org/10.1128/AAC.00813-07 DO - 10.1128/AAC.00813-07 ID - Passarell2008 ER - TY - JOUR AU - Drusano, G. L. AU - Preston, S. L. AU - Hardalo, C. AU - Hare, R. AU - Banfield, C. AU - Andes, D. AU - Vesga, O. AU - Craig, W. A. PY - 2001 DA - 2001// TI - Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint JO - Antimicrob Agents Chemother VL - 45 UR - https://doi.org/10.1128/AAC.45.1.13-22.2001 DO - 10.1128/AAC.45.1.13-22.2001 ID - Drusano2001 ER - TY - JOUR AU - Bradley, J. S. AU - Dudley, M. N. AU - Drusano, G. L. PY - 2003 DA - 2003// TI - Predicting efficacy of antiinfectives with pharmacodynamics and Monte Carlo simulation JO - Pediatr Infect Dis J VL - 22 UR - https://doi.org/10.1097/01.inf.0000094940.81959.14 DO - 10.1097/01.inf.0000094940.81959.14 ID - Bradley2003 ER - TY - STD TI - Gajdacs M, Urban E. Resistance trends and epidemiology of citrobacter-enterobacter-serratia in urinary tract infections of inpatients and outpatients (RECESUTI): a 10-year survey. Medicina (Kaunas). 2019;55(6):285. ID - ref39 ER - TY - JOUR AU - Zamoner, W. AU - Freitas, F. M. AU - Garms, D. S. AU - Oliveira, M. G. AU - Balbi, A. L. AU - Ponce, D. PY - 2016 DA - 2016// TI - Pharmacokinetics and pharmacodynamics of antibiotics in critically ill acute kidney injury patients JO - Pharmacol Res Perspect VL - 4 UR - https://doi.org/10.1002/prp2.280 DO - 10.1002/prp2.280 ID - Zamoner2016 ER - TY - JOUR AU - Ambrose, P. G. AU - Bhavnani, S. M. AU - Ellis-Grosse, E. J. AU - Drusano, G. L. PY - 2010 DA - 2010// TI - Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap! JO - Clin Infect Dis VL - 51 UR - https://doi.org/10.1086/653057 DO - 10.1086/653057 ID - Ambrose2010 ER - TY - JOUR AU - Pfausler, B. AU - Spiss, H. AU - Dittrich, P. AU - Zeitlinger, M. AU - Schmutzhard, E. AU - Joukhadar, C. PY - 2004 DA - 2004// TI - Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis JO - J Antimicrob Chemother VL - 53 UR - https://doi.org/10.1093/jac/dkh158 DO - 10.1093/jac/dkh158 ID - Pfausler2004 ER - TY - JOUR AU - Docobo-Perez, F. AU - Drusano, G. L. AU - Johnson, A. AU - Goodwin, J. AU - Whalley, S. AU - Ramos-Martin, V. AU - Ballestero-Tellez, M. AU - Rodriguez-Martinez, J. M. AU - Conejo, M. C. AU - Guilder, M. PY - 2015 DA - 2015// TI - Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance JO - Antimicrob Agents Chemother VL - 59 UR - https://doi.org/10.1128/AAC.00752-15 DO - 10.1128/AAC.00752-15 ID - Docobo-Perez2015 ER - TY - JOUR AU - Florent, A. AU - Chichmanian, R. M. AU - Cua, E. AU - Pulcini, C. PY - 2011 DA - 2011// TI - Adverse events associated with intravenous fosfomycin JO - Int J Antimicrob Agents VL - 37 UR - https://doi.org/10.1016/j.ijantimicag.2010.09.002 DO - 10.1016/j.ijantimicag.2010.09.002 ID - Florent2011 ER - TY - JOUR AU - Falagas, M. E. AU - Vouloumanou, E. K. AU - Samonis, G. AU - Vardakas, K. Z. PY - 2016 DA - 2016// TI - Fosfomycin JO - Clin Microbiol Rev VL - 29 UR - https://doi.org/10.1128/CMR.00068-15 DO - 10.1128/CMR.00068-15 ID - Falagas2016 ER - TY - STD TI - Wang C, Hao W, Jin Y, Shen C, Wang B. Pharmacokinetic/pharmacodynamic modeling of seven antimicrobials for empiric treatment of adult bloodstream infections with gram-negative bacteria in China. Microb Drug Resist. 2019;26(12):1559-67. ID - ref46 ER - TY - STD TI - FDA Drug Safety Communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning. 2013. https://www.fdagov/Drugs. Accessed 27 Sept 2013. UR - https://www.fdagov/Drugs ID - ref47 ER - TY - JOUR AU - Chen, Z. AU - Wu, J. AU - Zhang, Y. AU - Wei, J. AU - Leng, X. AU - Bi, J. AU - Li, R. AU - Yan, L. AU - Quan, Z. AU - Chen, X. PY - 2010 DA - 2010// TI - Efficacy and safety of tigecycline monotherapy vs imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial JO - BMC Infect Dis VL - 10 UR - https://doi.org/10.1186/1471-2334-10-217 DO - 10.1186/1471-2334-10-217 ID - Chen2010 ER - TY - JOUR AU - Freire, A. T. AU - Melnyk, V. AU - Kim, M. J. AU - Datsenko, O. AU - Dzyublik, O. AU - Glumcher, F. AU - Chuang, Y. C. AU - Maroko, R. T. AU - Dukart, G. AU - Cooper, C. A. AU - Korth-Bradley, J. M. AU - Dartois, N. AU - Gandjini, H. PY - 2010 DA - 2010// TI - Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia JO - Diagn Microbiol Infect Dis VL - 68 UR - https://doi.org/10.1016/j.diagmicrobio.2010.05.012 DO - 10.1016/j.diagmicrobio.2010.05.012 ID - Freire2010 ER - TY - JOUR AU - Yamashita, N. AU - Matschke, K. AU - Gandhi, A. AU - Korth-Bradley, J. PY - 2014 DA - 2014// TI - Tigecycline pharmacokinetics, tolerability, safety, and effect on intestinal microflora in healthy Japanese male subjects JO - J Clin Pharmacol VL - 54 UR - https://doi.org/10.1002/jcph.236 DO - 10.1002/jcph.236 ID - Yamashita2014 ER - TY - JOUR AU - Ramirez, J. AU - Dartois, N. AU - Gandjini, H. AU - Yan, J. L. AU - Korth-Bradley, J. AU - McGovern, P. C. PY - 2013 DA - 2013// TI - Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.01232-12 DO - 10.1128/AAC.01232-12 ID - Ramirez2013 ER - TY - JOUR AU - Vardakas, K. Z. AU - Matthaiou, D. K. AU - Falagas, M. E. AU - Antypa, E. AU - Koteli, A. AU - Antoniadou, E. PY - 2015 DA - 2015// TI - Tigecycline for carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit JO - Infect Dis (Lond) VL - 47 UR - https://doi.org/10.3109/23744235.2015.1049659 DO - 10.3109/23744235.2015.1049659 ID - Vardakas2015 ER - TY - JOUR AU - Gong, J. AU - Su, D. AU - Shang, J. AU - Yu, H. AU - Du, G. AU - Lin, Y. AU - Sun, Z. AU - Liu, G. PY - 2019 DA - 2019// TI - Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: a meta-analysis JO - Medicine (Baltimore) VL - 98 UR - https://doi.org/10.1097/MD.0000000000017091 DO - 10.1097/MD.0000000000017091 ID - Gong2019 ER - TY - JOUR AU - Dalfino, L. AU - Puntillo, F. AU - Mosca, A. AU - Monno, R. AU - Spada, M. L. AU - Coppolecchia, S. AU - Miragliotta, G. AU - Bruno, F. AU - Brienza, N. PY - 2012 DA - 2012// TI - High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study JO - Clin Infect Dis VL - 54 UR - https://doi.org/10.1093/cid/cis286 DO - 10.1093/cid/cis286 ID - Dalfino2012 ER - TY - JOUR AU - Garnacho-Montero, J. AU - Ortiz-Leyba, C. AU - Jimenez-Jimenez, F. J. AU - Barrero-Almodovar, A. E. AU - Garcia-Garmendia, J. L. AU - Bernabeu-Wittel, I. M. AU - Gallego-Lara, S. L. AU - Madrazo-Osuna, J. PY - 2003 DA - 2003// TI - Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP JO - Clin Infect Dis VL - 36 UR - https://doi.org/10.1086/374337 DO - 10.1086/374337 ID - Garnacho-Montero2003 ER - TY - JOUR AU - Kallel, H. AU - Hergafi, L. AU - Bahloul, M. AU - Hakim, A. AU - Dammak, H. AU - Chelly, H. AU - Hamida, C. B. AU - Chaari, A. AU - Rekik, N. AU - Bouaziz, M. PY - 2007 DA - 2007// TI - Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study JO - Intensive Care Med VL - 33 UR - https://doi.org/10.1007/s00134-007-0675-2 DO - 10.1007/s00134-007-0675-2 ID - Kallel2007 ER - TY - JOUR AU - Imberti, R. AU - Cusato, M. AU - Villani, P. AU - Carnevale, L. AU - Iotti, G. A. AU - Langer, M. AU - Regazzi, M. PY - 2010 DA - 2010// TI - Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration JO - Chest VL - 138 UR - https://doi.org/10.1378/chest.10-0463 DO - 10.1378/chest.10-0463 ID - Imberti2010 ER - TY - JOUR AU - Poudyal, A. AU - Howden, B. P. AU - Bell, J. M. AU - Gao, W. AU - Owen, R. J. AU - Turnidge, J. D. AU - Nation, R. L. AU - Li, J. PY - 2008 DA - 2008// TI - In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae JO - J Antimicrob Chemother VL - 62 UR - https://doi.org/10.1093/jac/dkn425 DO - 10.1093/jac/dkn425 ID - Poudyal2008 ER - TY - JOUR AU - Zusman, O. AU - Altunin, S. AU - Koppel, F. AU - Dishon Benattar, Y. AU - Gedik, H. AU - Paul, M. PY - 2017 DA - 2017// TI - Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis JO - J Antimicrob Chemother VL - 72 UR - https://doi.org/10.1093/jac/dkw377 DO - 10.1093/jac/dkw377 ID - Zusman2017 ER - TY - JOUR AU - Bialvaei, A. Z. AU - Samadi Kafil, H. PY - 2015 DA - 2015// TI - Colistin, mechanisms and prevalence of resistance JO - Curr Med Res Opin VL - 31 UR - https://doi.org/10.1185/03007995.2015.1018989 DO - 10.1185/03007995.2015.1018989 ID - Bialvaei2015 ER - TY - JOUR AU - Liu, Y. Y. AU - Wang, Y. AU - Walsh, T. R. AU - Yi, L. X. AU - Zhang, R. AU - Spencer, J. AU - Doi, Y. AU - Tian, G. AU - Dong, B. AU - Huang, X. AU - Yu, L. F. AU - Gu, D. AU - Ren, H. AU - Chen, X. AU - Lv, L. AU - He, D. AU - Zhou, H. AU - Liang, Z. AU - Liu, J. H. AU - Shen, J. PY - 2016 DA - 2016// TI - Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study JO - Lancet Infect Dis VL - 16 UR - https://doi.org/10.1016/S1473-3099(15)00424-7 DO - 10.1016/S1473-3099(15)00424-7 ID - Liu2016 ER - TY - JOUR AU - Nicasio, A. M. AU - Crandon, J. L. AU - Nicolau, D. P. PY - 2009 DA - 2009// TI - In vivo pharmacodynamic profile of tigecycline against phenotypically diverse Escherichia coli and Klebsiella pneumoniae isolates JO - Antimicrob Agents Chemother VL - 53 UR - https://doi.org/10.1128/AAC.01678-08 DO - 10.1128/AAC.01678-08 ID - Nicasio2009 ER -